HCP, Inc. (NYSE: HCP) reported Q2 FFO of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $469.55 million versus the consensus estimate of $465.37 million.

GUIDANCE:

HCP, Inc. sees FY2018 FFO of $1.79-$1.83, versus the consensus of $1.81.

For earnings history and earnings-related data on HCP, Inc. (HCP) click here.